Advanced Filters
noise

Jungnang-Gu, Korea, Republic of Clinical Trials

A listing of Jungnang-Gu, Korea, Republic of clinical trials actively recruiting patients volunteers.

Found 1,096 clinical trials
C Cheol Ung Choi, M.D., Ph.D.

Gangwon PCI Prospective Registry

Comparison of Biolimus-eluting stent, Biomatrix, or Biomatrix Flex stent, Biosensors, Singapore Everolimus-eluting stent, Xience V, or Xience Prime, or Xience Xpedition stent, Abbott, USA Zotarolimus-eluting stent, Endeavor Resolute, or Endeavor Resolute Integrity stent Medtronic, USA in patients with coronary artery disease treated with percutaneous coronary intervention

19 years of age All Phase N/A
S Seokjin Kim, MD.Phd

Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study III

This prospective study enrolls patients who are diagnosed with aggressive lymphoma including Hodgkin and non-Hodgkin lymphomas. Enrolled patients will be treated according to our institution' treatment policy in clinical practice. The disease status including response to therapy and survival status will be regularly updated during the study period. Patients' serum …

20 - 90 years of age All Phase N/A
C CHANG-WOOK NAM, MD

Drug-Eluting Balloon Registry in Routine Clinical Practice

The purpose of this study is to evaluate long-term effectiveness and safety of patients with coronary disease treated with drug eluting balloon in real world practice.

20 years of age All Phase N/A

Korean Brain Aging Study for Early Diagnosis and Prediction of Alzheimer's disease2 (KBASE2)

The KBASE2 is the second phase of the KBASE project, which consists of roll-over participants from the first phase of the KBASE as well as newly enrolled participants with varying degrees of cognitive functions (e.g. individuals with normal cognition, mild cognitive impairment, or AD dementia). In addition to the aims …

20 - 90 years of age All Phase N/A
S Sang-Il Min, MD

Kidney Volume in Live Donors Kidney Transplant Donors and Recipients

The investigators aim to investigate the association between renal volume measured through pre-donation CT auto-segmentation and postoperative renal function of both donors and recipients. After establishing the statistical significance of the association, the investigators intend to create and validate predictive models for renal function at surgery, 1 year, and 3 …

18 years of age All Phase N/A
S Seung-Jung Park, MD,PhD

Study of the Natural History of FFR Guided Percutaneous Coronary Intervention

About 15,000 patients with FFR (Fractional Flow Reserve) will be enrolled and evaluated for the natural history of coronary lesions at 2 years clinical and imaging follow-up.

35 years of age All Phase N/A
Y Yasuhiro Katsumata

Validation of the Lupus Low Disease Activity State (LLDAS) in the Asia Pacific Region

Lupus Low Disease Activity State (LLDAS) study is an international, multi-centre prospective study, developed by the Asia Pacific Lupus Collaboration (APLC) to investigate whether the attainment of LLDAS is associated with improved outcomes in patients with Systemic Lupus Erythematosus (SLE). SLE, or lupus, is the archetypal multisystem autoimmune disease, with …

18 years of age All Phase N/A
D Donghoon Choi

Korean Vascular Intervention Society Multicenter Registry Study on Outcomes of Endovascular Therapy in Lower Limb Artery Diseases (K-VIS ELLA): (A Retrospective & Prospective Observational Study)

Study design: multicenter retrospective and prospective observational study Study Cohort : Retrospective cohort: This cohort retrospectively enrolls patients with lower extremity artery disease who underwent endovascular treatment from January 2006 to the date of approval by IRB in the participating hospitals. Informed consent was waived by IRB. Prospective cohort: This …

20 years of age All Phase N/A
W Wouter Hoefsloot, MD, PhD

A Prospective, Multicenter, Single-arm MAC-PD Cohort: a NTM-NET and ESGMYC Collaborative Study

To gain insight in the effectiveness of, adherence and adjustments to guideline-based three-drug antimycobacterial therapy in patients with Mycobacterium avium complex pulmonary disease (MAC-PD) during the first 6 months of treatment.

18 years of age All Phase N/A

Neurovascular Product Surveillance Registry

Post market surveillance registry

18 years of age All Phase N/A

Simplify language using AI